Insider Shareholders with Direct Ownership of Sage Therapeutics, Inc. (SAGE)
This section provides a comprehensive overview of the insiders with direct ownership of Sage Therapeutics, Inc. (SAGE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Sage Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 17,842 | 0 | 320,659 $2.15 Million | 1 |
Jun 16, 2021
Added 5.27%
|
|
|
Albert Robichaud
Chief Scientific Officer |
11,175 | 3,387 | 145,553 $978,116 | 6 |
Feb 03, 2023
Reduced 0.77%
|
| 97,988 | 24,472 | 128,046 $860,469 | 15 |
Nov 28, 2023
Reduced 2.98%
|
|
|
Barry E Greene
President and CEO |
97,340 | 12,273 | 85,067 $571,650 | 5 |
Aug 05, 2024
Reduced 12.61%
|
|
Kimi Iguchi
CFO & Treasurer |
63,692 | 7,339 | 81,405 $547,041 | 23 |
Aug 05, 2024
Reduced 4.28%
|
|
Anne Marie Cook
SVP, GC & Secretary |
39,400 | 8,917 | 24,040 $161,548 | 11 |
Aug 05, 2024
Reduced 15.78%
|
|
Christopher Benecchi
Chief Business Officer |
36,450 | 6,874 | 18,487 $124,232 | 5 |
Aug 05, 2024
Reduced 20.46%
|
|
Stephen Kanes
Chief Medical Officer |
7,300 | 2,121 | 13,471 $90,525 | 4 |
Oct 19, 2021
Reduced 7.68%
|
|
Laura Gault
Chief Medical Officer |
24,750 | 3,288 | 10,737 $72,152 | 3 |
Aug 05, 2024
Reduced 23.44%
|
| 8,000 | 0 | 8,000 $53,760 | 1 |
May 05, 2022
Added 50.0%
|
|
| 3,000 | 0 | 3,000 $20,160 | 2 |
Aug 09, 2023
Added 40.0%
|